logo

North America Cardiac Assist Devices Market Size (2024 - 2029)

The market size for cardiac assist devices in North America is experiencing growth due to advancements in technology and new applications of existing treatments. This growth is driven by factors such as the shortage of donor hearts for transplantation, an aging population, and the rising prevalence of heart diseases, which increase the demand for these devices in patients with severe heart conditions. However, the market expansion is challenged by the availability of alternative treatments like pacemakers and the risks associated with device implantation.

Home Market Analysis Healthcare Research Device Drug Combination Research Diagnostics and Therapeutics Research Cardiovascular Research North America Cardiac Assist Devices Industry Market Size

Market Size of North America Cardiac Assist Devices Industry

North America Cardiac Assist Devices Market Size
Study Period 2019 - 2029
Base Year For Estimation 2023
Forecast Data Period 2024 - 2029
Historical Data Period 2019 - 2022
CAGR 8.10 %

Major Players

North America Cardiac Assist Devices Market key players

*Disclaimer: Major Players sorted in no particular order

North America Cardiac Assist Devices Market Analysis

Continuous rapid advancements in the assist devices technologies and the novel applications of the existing treatments have led to an increase in the demand for cardiac assist devices. Other factors responsible for the market growth are lack of donor's hearts for transplantation, aging population, and increasing heart diseases. These factors are leading to an increase in the usage of cardiac assist devices implantations in patients with severe heart complications. As per the report from the American Heart Association on heart disease and stroke, in 2017, approximately 800,000 deaths were caused due to cardiovascular diseases. However, the availability of alternative treatments, like pacemakers, and the risk associated with device implantation are likely to impede the market for cardiac assist devices.

North America Cardiac Assist Devices Industry Segmentation

As per the scope of the report, assist devices are defined as the type of mechanical pumps that work along with the heart, to improve the pumping efficiency and maintain optimum blood flow throughout the body. Cardiac-assist devices are used to treat end-stage heart failure and are determined by the needs of the individual. They are of three types, namely, ventricular assist devices, intra-aortic balloon pumps (IABPs), and the total artificial heart.

By Product
Intra-aortic Balloon Pumps
Total Artificial Heart
Ventricular Assist Devices
Left Ventricular Assist Device
Right Ventricular Assist Device
Geography
North America
United States
Canada
Mexico
Need A Different Region Or Segment?
Customize Now

North America Cardiac Assist Devices Market Size Summary

The North American cardiac assist devices market is experiencing significant growth due to continuous advancements in technology and the novel applications of existing treatments. The increasing prevalence of heart diseases, coupled with a shortage of donor hearts for transplantation and an aging population, has driven the demand for these devices. Cardiac assist devices are becoming more prevalent in patients with severe heart complications, as they offer a solution where traditional heart transplantation is not feasible. Despite the availability of alternative treatments like pacemakers, the risks associated with device implantation pose challenges to market growth. The total artificial heart is recognized as a leading long-term solution for advanced heart failure, while extracorporeal and ventricular assist devices serve as temporary measures.

The market is characterized by a high degree of fragmentation, with numerous prominent players actively engaging in collaborations, mergers, and acquisitions to expand their market presence. Companies are investing in research and development to enhance product quality, reduce manufacturing costs, and develop safer devices that improve patient compliance and safety. Key players in the market include Abiomed Inc., Abbott Laboratories, Medtronic, Syncardia, and Berlin Heart Gmbh, among others. These companies are pivotal in driving innovation and addressing the growing demand for cardiac assist devices in North America.

Explore More

North America Cardiac Assist Devices Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Increasing Prevalence of Heart Diseases

      2. 1.2.2 Advancements in Technology

      3. 1.2.3 Shortage of Heart Donors in Transplantation

    3. 1.3 Market Restraints

      1. 1.3.1 Risk Associated with Device Implantation

    4. 1.4 Porter's Five Forces Analysis

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION

    1. 2.1 By Product

      1. 2.1.1 Intra-aortic Balloon Pumps

      2. 2.1.2 Total Artificial Heart

      3. 2.1.3 Ventricular Assist Devices

        1. 2.1.3.1 Left Ventricular Assist Device

        2. 2.1.3.2 Right Ventricular Assist Device

    2. 2.2 Geography

      1. 2.2.1 North America

        1. 2.2.1.1 United States

        2. 2.2.1.2 Canada

        3. 2.2.1.3 Mexico

North America Cardiac Assist Devices Market Size FAQs

The North America Cardiac Assist Devices Market is projected to register a CAGR of 8.10% during the forecast period (2024-2029)

Abiomed Inc., Abbott Laboratories, Medtronic, (LivaNova PLC) CardiacAssist Inc. and SynCardia Systems LLC are the major companies operating in the North America Cardiac Assist Devices Market.

North America Cardiac Assist Devices Market Report Snapshots

North America Cardiac Assist Devices Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)